Michael Caglia, MD
Dermatology · Midland, TXNPI 1568789550
Payments from drug & device makers
Across 713 payments — averaging $311.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Scientific Affairs, LLC$69K
- Sun Pharmaceutical Industries Inc.$60K
- Bristol Myers Squibb$47K
- Amgen$34K
- AbbVie$2K
- Novartis$1K
- plus $7K from 25 others
What the payments were for
- Consulting fees$5,1682%
- Speaking & faculty fees$171,69077%
- Travel & lodging$29,91713%
- Food & beverage$15,0367%
- Education$3050%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Scientific Affairs, LLC | 58 | $69,440 |
| Sun Pharmaceutical Industries Inc. | 54 | $60,408 |
| Bristol Myers Squibb | 42 | $47,373 |
| Amgen | 66 | $34,019 |
| AbbVie(2 entities) | 104 | $2,488 |
| Novartis | 70 | $1,230 |
| E.r. Squibb & Sons, L.L.C. | 34 | $1,008 |
| Mayne Pharma Commercial LLC | 75 | $1,003 |
| Incyte Corporation | 28 | $751 |
| Arcutis Biotherapeutics, Inc. | 26 | $642 |
| Regeneron Healthcare Solutions, Inc. | 17 | $551 |
| Johnson & Johnson | 21 | $470 |
| UCB, Inc. | 13 | $446 |
| Dermavant Sciences, Inc. | 9 | $356 |
| Lilly USA, LLC | 15 | $354 |
| Journey Medical Corporation | 11 | $258 |
| LEO Pharma Inc. | 10 | $242 |
| Pfizer | 14 | $205 |
| Sanofi | 7 | $188 |
| Organon | 8 | $123 |
| Galderma Laboratories, L.p. | 8 | $119 |
| Biofrontera Inc. | 6 | $104 |
| Boehringer Ingelheim | 4 | $83 |
| Almirall LLC | 3 | $62 |
| Genentech USA, Inc. | 3 | $50 |
| Tactile Systems Technology Inc | 2 | $48 |
| Kyowa Kirin, Inc. | 1 | $24 |
| DUSA Pharmaceuticals, Inc. | 1 | $20 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $20 |
| Dermira, Inc. | 1 | $18 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$222,116 in reported general payments places this provider in the 90th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 14 | $149,832 |
| Taltz SyringeIxekizumab | 11 | $88,463 |
| Fluorouracil | 35 | $2,765 |
| CiclopiroxCiclopirox Olamine | 39 | $1,727 |
| Tacrolimus | 14 | $1,152 |
| Ketoconazole | 84 | $1,080 |
| Fluocinonide | 27 | $993 |
| Triamcinolone Acetonide | 64 | $900 |
| Clobetasol Propionate | 24 | $660 |
| Doxycycline Hyclate | 20 | $292 |
| Gabapentin | 18 | $260 |
| ValacyclovirValacyclovir Hcl | 11 | $203 |
| Finasteride | 12 | $164 |
| Hydroxychloroquine Sulfate | 17 | $164 |
| Terbinafine Hcl | 20 | $162 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Midland
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
- Craig TellerBellaire$7.7M
- Patricia LeeWebster$7.2M
- Jennifer CatherDallas$4.9M
- Michael MigdenHouston$3.7M
- Martin MenterDallas$3.7M
- Janet DuboisAustin$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.